Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Jungnickel

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Annals of Pharmacotherapy|May 1, 1996
Cholesterol-lowering therapy: is there really a controversy?P W Jungnickel
Clinical Therapeutics|December 16, 2000
Pantoprazole: a new proton pump inhibitorP W Jungnickel
DICP : the Annals of Pharmacotherapy|September 1, 1991
Comment: adverse-effect profile of sustained-release niacinP W Jungnickel, P A Maloley
The New England Journal of Medicine|March 19, 1992
SucralfateP W Jungnickel, K A Cantral
Annals of Internal Medicine|March 1, 1995
Pharmacoepidemiology of niacinP W Jungnickel, P A Maloley
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|January 13, 1998
Evaluation of community pharmacists' experiences with cholesterol screening programsP W Jungnickel, D A Wisehart
Clinical Pharmacy|August 1, 1992
Pravastatin: a new drug for the treatment of hypercholesterolemiaP W Jungnickel, K A Cantral, P A Maloley
Drug Intelligence & Clinical Pharmacy|July 1, 1988
Possible ketoconazole-induced hypoglycemiaB L Lobo, L J Miwa, P W Jungnickel
Clinical Pharmacy|January 1, 1987
Acceptability of cholestyramine or colestipol combinations with six vehiclesM S Shaefer, P W Jungnickel, E W Jacobs, et al.
Clinical Pharmacy|January 1, 1988
Effect of sucralfate on theophylline absorption in healthy volunteersK A Cantral, L J Schaaf, P W Jungnickel, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Annals of Pharmacotherapy|May 1, 1996
Cholesterol-lowering therapy: is there really a controversy?P W Jungnickel
Clinical Therapeutics|December 16, 2000
Pantoprazole: a new proton pump inhibitorP W Jungnickel
DICP : the Annals of Pharmacotherapy|September 1, 1991
Comment: adverse-effect profile of sustained-release niacinP W Jungnickel, P A Maloley
The New England Journal of Medicine|March 19, 1992
SucralfateP W Jungnickel, K A Cantral
Annals of Internal Medicine|March 1, 1995
Pharmacoepidemiology of niacinP W Jungnickel, P A Maloley
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|January 13, 1998
Evaluation of community pharmacists' experiences with cholesterol screening programsP W Jungnickel, D A Wisehart
Clinical Pharmacy|August 1, 1992
Pravastatin: a new drug for the treatment of hypercholesterolemiaP W Jungnickel, K A Cantral, P A Maloley
Drug Intelligence & Clinical Pharmacy|July 1, 1988
Possible ketoconazole-induced hypoglycemiaB L Lobo, L J Miwa, P W Jungnickel
Clinical Pharmacy|January 1, 1987
Acceptability of cholestyramine or colestipol combinations with six vehiclesM S Shaefer, P W Jungnickel, E W Jacobs, et al.
Clinical Pharmacy|January 1, 1988
Effect of sucralfate on theophylline absorption in healthy volunteersK A Cantral, L J Schaaf, P W Jungnickel, et al.
Pageof 2